Mainz Biomed Bv Stock Price To Sales

MYNZ Stock

USD 0.22 0.04 15.38%

Mainz Biomed BV fundamentals help investors to digest information that contributes to Mainz Biomed's financial success or failures. It also enables traders to predict the movement of Mainz Stock. The fundamental analysis module provides a way to measure Mainz Biomed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mainz Biomed stock.

		Last Reported	Projected for Next Year
	Price To Sales Ratio	21.04	19.99

Price To Sales Ratio is likely to drop to 19.99 in 2024.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Mainz Biomed BV Company Price To Sales Analysis

Mainz Biomed's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

P/S

MV Per Share

Revenue Per Share

More About Price To Sales | All Equity Analysis

Current Mainz Biomed Price To Sales

17.87 X

Most of Mainz Biomed's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mainz Biomed BV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Mainz Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for Mainz Biomed is extremely important. It helps to project a fair market value of Mainz Stock properly, considering its historical fundamentals such as Price To Sales. Since Mainz Biomed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mainz Biomed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mainz Biomed's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Net Tangible Assets	Property Plant Equipment	Intangible Assets
Total Assets		0.94	0.93	-0.83	-0.85	0.83	0.72	0.8	0.79	0.99	0.63	0.98	0.87	0.73	0.65	0.87	0.93	-0.83	-0.46
Total Stockholder Equity	0.94		0.93	-0.96	-0.67	0.65	0.72	0.62	0.54	0.97	0.4	0.99	0.65	0.9	0.42	0.65	0.85	-0.69	-0.28
Current Deferred Revenue	0.93	0.93		-0.86	-0.7	0.71	0.9	0.6	0.64	0.94	0.47	0.95	0.76	0.81	0.49	0.76	0.92	-0.77	-0.33
Net Debt	-0.83	-0.96	-0.86		0.43	-0.41	-0.64	-0.38	-0.33	-0.88	-0.12	-0.92	-0.45	-0.99	-0.15	-0.45	-0.68	0.45	0.0
Retained Earnings	-0.85	-0.67	-0.7	0.43		-0.99	-0.57	-0.98	-0.91	-0.8	-0.94	-0.75	-0.94	-0.28	-0.95	-0.94	-0.9	0.96	0.84
Accounts Payable	0.83	0.65	0.71	-0.41	-0.99		0.62	0.96	0.88	0.78	0.95	0.74	0.92	0.27	0.96	0.92	0.92	-0.99	-0.87
Long Term Debt	0.72	0.72	0.9	-0.64	-0.57	0.62		0.41	0.49	0.71	0.42	0.74	0.62	0.61	0.43	0.62	0.86	-0.73	-0.37
Net Receivables	0.8	0.62	0.6	-0.38	-0.98	0.96	0.41		0.87	0.76	0.94	0.7	0.88	0.23	0.95	0.88	0.82	-0.91	-0.84
Total Liab	0.79	0.54	0.64	-0.33	-0.91	0.88	0.49	0.87		0.73	0.85	0.65	0.98	0.2	0.86	0.98	0.78	-0.82	-0.63
Net Invested Capital	0.99	0.97	0.94	-0.88	-0.8	0.78	0.71	0.76	0.73		0.56	0.99	0.81	0.79	0.59	0.81	0.91	-0.78	-0.4
Short Long Term Debt	0.63	0.4	0.47	-0.12	-0.94	0.95	0.42	0.94	0.85	0.56		0.5	0.85	-0.04	1.0	0.85	0.76	-0.91	-0.94
Total Current Assets	0.98	0.99	0.95	-0.92	-0.75	0.74	0.74	0.7	0.65	0.99	0.5		0.75	0.85	0.52	0.75	0.9	-0.76	-0.37
Capital Stock	0.87	0.65	0.76	-0.45	-0.94	0.92	0.62	0.88	0.98	0.81	0.85	0.75		0.32	0.86	1.0	0.88	-0.89	-0.65
Net Working Capital	0.73	0.9	0.81	-0.99	-0.28	0.27	0.61	0.23	0.2	0.79	-0.04	0.85	0.32		-0.01	0.32	0.57	-0.32	0.14
Short Term Debt	0.65	0.42	0.49	-0.15	-0.95	0.96	0.43	0.95	0.86	0.59	1.0	0.52	0.86	-0.01		0.86	0.77	-0.92	-0.94
Common Stock	0.87	0.65	0.76	-0.45	-0.94	0.92	0.62	0.88	0.98	0.81	0.85	0.75	1.0	0.32	0.86		0.88	-0.89	-0.65
Net Tangible Assets	0.93	0.85	0.92	-0.68	-0.9	0.92	0.86	0.82	0.78	0.91	0.76	0.9	0.88	0.57	0.77	0.88		-0.95	-0.67
Property Plant Equipment	-0.83	-0.69	-0.77	0.45	0.96	-0.99	-0.73	-0.91	-0.82	-0.78	-0.91	-0.76	-0.89	-0.32	-0.92	-0.89	-0.95		0.86
Intangible Assets	-0.46	-0.28	-0.33	0.0	0.84	-0.87	-0.37	-0.84	-0.63	-0.4	-0.94	-0.37	-0.65	0.14	-0.94	-0.65	-0.67	0.86

Click cells to compare fundamentals

Mainz Price To Sales Historical Pattern

Today, most investors in Mainz Biomed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mainz Biomed's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Mainz Biomed price to sales as a starting point in their analysis.

Mainz Biomed Price To Sales

Timeline

The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Competition

Predict Mainz Biomed

Price To Sales Ratio Over Time

Mainz Price To Sales Ratio

Price To Sales Ratio

19.99

At this time, Mainz Biomed's Price To Sales Ratio is fairly stable compared to the past year.

Based on the latest financial disclosure, Mainz Biomed BV has a Price To Sales of 17.8744 times. This is 16.47% lower than that of the Biotechnology sector and 53.96% higher than that of the Health Care industry. The price to sales for all United States stocks is 56.52% lower than that of the firm.

Mainz Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mainz Biomed's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mainz Biomed could also be used in its relative valuation, which is a method of valuing Mainz Biomed by comparing valuation metrics of similar companies.

Mainz Biomed is currently under evaluation in price to sales category among its peers.

Mainz Fundamentals

	Return On Equity	-43.34
	Return On Asset	-0.99
	Operating Margin	(18.83) %
	Current Valuation	21.38 M
	Shares Outstanding	64.04 M
	Shares Owned By Insiders	20.21 %
	Shares Owned By Institutions	0.88 %
	Number Of Shares Shorted	3.57 M
	Price To Book	1.72 X
	Price To Sales	17.87 X
	Revenue	895.48 K
	Gross Profit	177.62 K
	EBITDA	(25.01 M)
	Net Income	(26.3 M)
	Cash And Equivalents	26.01 M
	Cash Per Share	1.80 X
	Total Debt	7.42 M
	Debt To Equity	0.10 %
	Current Ratio	10.83 X
	Book Value Per Share	(0.16) X
	Cash Flow From Operations	(21.94 M)
	Short Ratio	0.76 X
	Earnings Per Share	(1.11) X
	Target Price	2.0
	Number Of Employees	65
	Beta	0.076
	Market Capitalization	16.39 M
	Total Asset	15.41 M
	Retained Earnings	(69.33 M)
	Working Capital	(257.15 K)
	Net Asset	15.41 M

About Mainz Biomed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Mainz Biomed BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mainz Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mainz Biomed BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC